As one of the nations top 25 public research universities, UConn is home to many faculty and student inventors. The discoveries they make in the lab could some day become products and services that help society. They could also launch Connecticut companies that provide high paying jobs in the state. But its not always easy to think like an entrepreneur when youve been trained as an academic researcher.
Abhijit (Jit) Banerjee, Ph.D., MBA, is leading UConns mission to help more faculty and students participate in commercialization activities. Banerjee, who has extensive experience facilitating public-private partnerships, joined UConns Office of the Vice President for Research as Associate Vice President, Innovation and Entrepreneurship in May 2020. He leads Technology Commercialization Services, a group that specializes in transforming UConn inventions into products, services, and companies that help society.
Our efforts to bring the fruits of our research to the world are tremendously strengthened by Jits arrival at UConn, says President Thomas Katsouleas. His background, skills, and passion for the work are going to help us become even more prolific and successful in demonstrating the value of the world-class research being done at UConn.
Banerjee recently answered a few questions about becoming a Husky during a pandemic and the importance of innovation to tackle the worlds great challenges.
Connecticut has a rich history of innovation and invention. How does UConn contribute to this legacy? What do you think the University can do to help the states economic health now and in the future?
The innovation engine runs 24/7, 365 days at UConn. The Universitys 14 schools and colleges are filled with world-class faculty and students who are building on UConns strong legacy of innovation. Our footprint isnt limited to the local geography either. UConn has a statewide impact, with programs like the UConn Technology Incubation Program (TIP), a flagship program that supports UConn companies as well as external ventures. TIPs three locations in Storrs, Farmington, and the soon-to-be-launched Stamford site support the states economy because it grows and attracts companies that want to locate in Connecticut and will create jobs here. Another example is the Innovation Partnership Building at UConn Tech Park, which is a world-class engineering living lab that is an asset to the states engineering and manufacturing industry.
With all of these hubs of innovation, I am convinced that the University still has too many well kept secrets for businesses and citizens around our state. We have expert faculty in every field, talented students to bolster the states innovation workforce, and unparalleled facilities to help solve problems and make breakthroughs for any industry sector, from manufacturing to personalized medicine.
In a fiercely competitive national environment where every state is aggressively looking to expand their funding and improve their economic health, success comes when the state, its agencies, and major innovation engines like UConn work hand-in-hand. I plan to do everything I can to help UConn continue our collaborative approach to support state economic development goals.
In your newly created role within the Office of the Vice President for Research, you are responsible for leading UConns efforts to enhance entrepreneurship, innovation, and technology commercialization for UConn companies and external ventures. How do you and your team support these efforts?
The Technology Commercialization Service (TCS) team is responsible for protecting intellectual property that is generated at UConn and bringing inventions from bench to marketplace or bedside through commercialization. A major focus for TCS is fostering an entrepreneurial ecosystem that enables faculty and students to pursue commercialization of their discoveries whether it be through licensing to existing companies or forming startups. The TCS team has dedicated and passionate individuals who are deeply committed to the University and all faculty, regardless of the discipline.
As Ive met with leaders at each school and college, it has become clear that there is an opportunity for TCS to take much bigger and strategic roles across the University, and we are excited to take that on.
How has the pandemic affected innovation, in your opinion? What challenges and opportunities does it provide for faculty and student innovators?
The impact of COVID-19 on global well-being is now being felt in every sphere, from mental health to the economy to education. This pandemic has taught us to quickly adapt, pivot, and rely on both instincts and innovation to get through this and survive the new normal.
As the world collectively works to find a vaccine for this pathogen, we shouldnt stop innovating and seeking solutions for other major challenges we still face. Climate change, wild fires, tsunami, and hurricanes are impacting both human lives and our ecosystem. As we know, any slight imbalance in this ecosystem can cause disasters which are often irreversible. There are thousands of other conditions that still need effective treatments. We can still do more to develop innovative technologies that support the defense sector. For all of these problems, science, innovation, and commercialization can help find solutions. I am confident UConn inventors will be part of the solution and TCS is here to support them on that path.
You joined UConn while the University was still in the middle of the COVID-19 ramp down. How do you like being a Husky so far during these unprecedented times?
COVID-19 has changed the way we conduct business and interact, and for the unforeseen future, we need to accept this as the new normal. Our individual responsibility to stay healthy and follow guidance from scientific experts to reduce risk of COVID-19 exposure and infection adds another layer of complexity. From what Ive seen so far, at the individual and organizational level, UConn Nation is pivoting and adapting to continue working towards our educational, research, and service goals.
But I have to admit that even before I came to UConn, I felt an affinity for Husky Nation, since our family dog was a Siberian Husky named Mishi. We recently lost him to cancer, but he brought out the best in us as humans and I can see that same core value in everyone Ive met so far at UConn.
To learn more about UConn technologies and startups, visit http://www.innovation.uconn.edu
Follow UConn Research on Twitter & LinkedIn.
Read the original here:
Q&A: The Magic of University Entrepreneurship - UConn Today
- Oncology Precision Medicine Market Research, Industry Trends and Global Forecasts, 2035 - Rising Partnership and ... - PR Newswire - March 18th, 2024
- 3 Precision Medicine Stocks That Could Benefit From the Industry's Rise - InvestorPlace - March 18th, 2024
- Prime Editing Approach Provides a Faster, More Effective Way to Screen for Cancer Mutations - Inside Precision Medicine - March 18th, 2024
- Global Genomics Industry Research 2024-2031: Rising Adoption of Personalized Medicines and Gene Therapies ... - PR Newswire - March 18th, 2024
- CAR T-Cell Therapy Successfully Used to Treat Brain Tumors - Inside Precision Medicine - March 18th, 2024
- Revolutionizing Wellness: The Power of Personalised Health Tech - AutoGPT - March 18th, 2024
- Personalized medicine is coming, but who will have access to it? - March 10th, 2024
- Personalized medicine | Definition, Origins, Examples, & Ethical ... - March 10th, 2024
- Innovating for Individual Care: The Impact of USP on Personalized Medicine - March 10th, 2024
- AI and predictive medicine: Recent advances - News-Medical.Net - March 10th, 2024
- Personalized medicine is coming, but who will have access to it? - AAMC - March 10th, 2024
- Why personalized medicine is a business trend to watch in 2024 - HealthLeaders Media - March 10th, 2024
- AI helps cardiologists deliver personalized healthcarebut there is still plenty of work to do - Cardiovascular Business - March 10th, 2024
- Q&A: How AI and wearable technologies are transforming medicine - EMS1.com - March 10th, 2024
- HealthTech Revolution: Wearables, AI, and the Personalized Future of Healthcare - GearBrain - March 10th, 2024
- Redefining Healthcare: The Rise of Personalized Medicine and the Shift from Conventional Care - Medriva - March 10th, 2024
- Dr Kalinsky on Unanswered Questions Regarding Genomic Testing in HR+ Breast Cancer - OncLive - March 10th, 2024
- Chemotherapy Plus High Doses of Radiation Effective for Treating Non-Small Cell Lung Cancer - Inside Precision Medicine - January 17th, 2024
- It's Time to Fully Embrace Precision Medicine's Promise in Pediatrics - Healthcare Innovation - January 17th, 2024
- Special Report: Radiation Oncology Takeaways from RSNA23 - Imaging Technology News - January 17th, 2024
- Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing ... - PR Newswire - January 17th, 2024
- Simulations of the human body and advanced data promise more personalized medical treatment - Medical Xpress - January 17th, 2024
- United States Single Cell Genomics and Proteomics Growth Opportunities: The Integration of Multi-Omics Data to Drive ... - PR Newswire - January 17th, 2024
- Advances Usher In Era of Personalized Treatment for Obesity - Gastroenterology & Endoscopy News - January 17th, 2024
- Unveiling the Reality of Personalized Medicine: Yale Study Highlights Limitations in Current Predictive Models - Medriva - January 17th, 2024
- Digital Twins: The Future of Personalized Healthcare - BNN Breaking - January 17th, 2024
- Healthcare in 2024: A Vision of the Future | Future of Healthcare Predictions - Medriva - January 17th, 2024
- Utilization of the microbiome in personalized medicine - Nature.com - December 22nd, 2023
- Focusing on Women's Health - Inside Precision Medicine - December 22nd, 2023
- Revolutionizing Healthcare: Innovations in Regenerative Medicine Offer Hope - Inside Precision Medicine - December 22nd, 2023
- AI in Genomics Market Predicted to Grow at CAGR of 40.6% by 2031, with Revenue $9.8 Billion - PharmiWeb.com - December 22nd, 2023
- Innovative Technologies Transforming Cancer Treatment - BNN Breaking - December 22nd, 2023
- Antisense Oligonucleotides Industry Poised to Reach US$ 5519.6 Million by 2033-FMI Projection - PharmiWeb.com - December 22nd, 2023
- Live Cell Encapsulation Market To Reach USD 313.3 Million at a CAGR of 4% in 2032 - EIN News - April 23rd, 2023
- Cancer Therapeutics and Biotherapeutics Market is estimated to be US$ 506.8 billion by 2032 with a CAGR of - EIN News - April 7th, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 13th, 2023
- Gene Therapy Market Size (USD 46.5 Bn by 2030): A Growing Industry and Its Impact on Healthcare Systems - EIN News - March 13th, 2023
- Translating the Microbiome - Inside Precision Medicine - October 15th, 2022
- Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease Trials - Applied Clinical Trials Online - October 15th, 2022
- Global Cancer/Tumor Profiling Market Research Report to 2027 - Increasing Demand for Personalized Medicine Presents Opportunities -... - October 15th, 2022
- Cambridge biotech raises $168 million to fight cancer and other diseases - The Boston Globe - October 15th, 2022
- Perlmutter Cancer Center Medical Oncologist Provides Personalized Care to People with Breast Cancer - NYU Langone Health - October 15th, 2022
- Concierge Medicine's Continued Rise Illuminated by Specialdocs Consultants at the Industry's Leading Event - PR Newswire - October 15th, 2022
- Hormone Changes: The Star of Every Stage in Women's Sleep - Medscape - October 15th, 2022
- Could Xolair Be the First Biologic Treatment for Food Allergies? - Allergic Living - October 15th, 2022
- Matching Treatments to Your Genes - The Epoch Times - October 15th, 2022
- Global Monoclonal Antibodies (mAbs) Markets, 2018-2021 & 2022-2030 - Increasing R&D Activities Aimed at the Development of Novel Therapeutic mAbs -... - October 15th, 2022
- Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies - Business Wire - October 15th, 2022
- Learn Look Locate Partners with Genetic Testing Leader, Myriad Genetics, in Educational Campaign - PR Newswire - October 15th, 2022
- Important Mission By LG To Reinvent Society With Future Growth - Forbes - October 15th, 2022
- Scientists identify more than 12,000 spots in the human genome associated with height - Inverse - October 15th, 2022
- The future of cancer research | News - ND Newswire - October 15th, 2022
- Kyverna Therapeutics Names Peter Maag, Ph.D., as Chief Executive Officer - PR Newswire - October 15th, 2022
- Call for Accurate Automation in Healthcare Practices to drive the Laboratory Information Systems (LIS) Market | Future Market Insights, Inc. - Yahoo... - October 15th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Ma - Benzinga - October 15th, 2022
- Global Precision Medicine Software Market is projected to witness a healthy growth rate of 10% in the upcoming years - Bio-IT World - July 17th, 2022
- The Single-Cell Analysis Market Size To Almost Double By 2026 Due To A Rising Focus On Personalized Medicine As Per The Business Research Company's... - July 17th, 2022
- Northwell Health Partners with Google Cloud to Provide Proactive, Personalized Healthcare - PR Newswire - July 17th, 2022
- Leveraging whole blood based functional flow cytometry assays to open new perspectives for rheumatoid arthritis translational research | Scientific... - July 17th, 2022
- New Approaches Needed To Support Digitization Of Healthcare - Forbes - July 17th, 2022
- Outlook on the Microtome Global Market to 2027 - Increasing Demand for Personalized Medicine Presents Opp - Benzinga - July 17th, 2022
- Precision health perspectives - UCI News - July 17th, 2022
- The Worldwide Compound Management Industry is Expected to Reach $1.4 Billion by 2030 - ResearchAndMarkets.com - Business Wire - July 17th, 2022
- Thrive Pet Healthcare and FidoCure Announce An Expansive Pet Precision Health Partnership - Benzinga - Benzinga - July 17th, 2022
- Access to Myriad Genetics GeneSight Test Improves Depression Remission Rates In Largest Ever Mental Health PGx Randomized Controlled Trial - Yahoo... - July 17th, 2022
- Global Induced Pluripotent Stem Cell (iPSC) Market Report 2022: Rising Applications of iPSCs Fueling Industry Growth - ResearchAndMarkets.com -... - July 17th, 2022
- Research Antibodies and Reagents Market worth $16.1 Billion by 2027 Exclusive Report by MarketsandMarkets - Yahoo Finance - July 17th, 2022
- Global Custom Antibody Market Is Expected To Reach USD 742.27 Million At A CAGR Of 10.3% And Forecast To 2029 - Digital Journal - July 17th, 2022
- Personalized Medicine Coalition - Precision Medicine Advocacy and ... - June 8th, 2022
- Precision Medicine | FDA - June 8th, 2022
- Global Precision Medicine Software Market is anticipated to witness a lucrative CAGR of 10% - GlobeNewswire - June 8th, 2022
- Global Biomarkers Markets Research 2022-2027: Increased Adoption of Biomarkers in Personalized Medicine / Focus on Digital Biomarkers / Increased... - June 8th, 2022
- Every patient in this experimental drug trial saw their cancer disappear, researchers say - CBS News - June 8th, 2022
- The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the... - June 8th, 2022
- It's time to move past Aduhelm and focus on a broader Alzheimer's drug pipeline - STAT - June 8th, 2022
- Can the industry elevate the success rate of cancer trials? - OutSourcing-Pharma.com - June 8th, 2022
- Purdue Polytechnic Institute and Purdue University Global collaborating on partnership with the University of Puerto Rico - Purdue University - June 8th, 2022
- Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions - PR Newswire - June 8th, 2022
- AdhereTech and Massive Bio, Two of NYC Digital Health 100 most Promising Start-Ups, Announce AI-Enabled, Patient-Centric Oncology Solutions... - June 8th, 2022
- Time to Rethink Metformin as First-Line Therapy? Perspective from ADA 2022 - Endocrinology Network - June 8th, 2022